ArticleTherapeutics and clinical risk management2012
Pharmacological management of binge eating disorder: current and emerging treatment options.
Article in Therapeutics and clinical risk management, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02528409 (A Double-Blind, Placebo-Controlled Study of Vortioxetine in the Treatment of Binge Eating Disorder), which is not on this map. Cited by 25 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
A Double-Blind, Placebo-Controlled Study of Vortioxetine in the Treatment of Binge Eating Disorder
Who cites it
25 citing papers in PubMed, 70 citations in OpenAlex.
- A double-blind, placebo-controlled study of vortioxetine in the treatment of binge-eating disorder.The International journal of eating disorders · 2019Trial
- Putting the brakes on the "drive to eat": Pilot effects of naltrexone and reward-based eating on food cravings among obese women.Eating behaviors · 2015Trial
- Neurobehavioral Association Between Macroscopic Network Decoupling and Reduced Eating Impulsivity: A Longitudinal fMRI Study in Bulimia Nervosa.CNS neuroscience & therapeutics · 2026Article
- The effectiveness of glucagon-like peptide-1 receptor agonists (GLP-1RAs) on binge eating in patients with obesity: a systematic review and meta-analysis.EClinicalMedicine · 2026Article
- Precision obesity medicine: A phenotype-guided framework for pharmacologic therapy across the lifespan.Journal of endocrinological investigation · 2025Review
- Pharmacological management of binge eating disorder.The mental health clinician · 2025Article
- Advancements in the Diagnosis and Treatment of Eating Disorders in Children and Adolescents: Challenges, Progress, and Future Directions.Nutrients · 2025Review
- SipNose-topiramate: a potential novel approach to binge eating management.Journal of eating disorders · 2023Article
- Obesogenic Behavior and Binge Eating Disorder in an Elderly Female with Schizophrenia.Journal of obesity & metabolic syndrome · 2021Article
- A review of binge eating disorder and obesity.Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater · 2021Review
- Current Status of Evidence for a New Diagnosis: Food Addiction-A Literature Review.Frontiers in psychiatry · 2021Review
- The Opioid System and Food Intake: Use of Opiate Antagonists in Treatment of Binge Eating Disorder and Abnormal Eating Behavior.Journal of clinical medicine research · 2020Review
- Eating Disorders: An Evolutionary Psychoneuroimmunological Approach.Frontiers in psychology · 2019Article
- Meta-analysis of the effectiveness of psychological and medical treatments for binge-eating disorder (MetaBED): study protocol.BMJ open · 2017Review
- Wistar-Kyoto Female Rats Are More Susceptible to Develop Sugar Binging: A Comparison with Wistar Rats.Frontiers in nutrition · 2017Article
- Learning disease relationships from clinical drug trials.Journal of the American Medical Informatics Association : JAMIA · 2017Article
- Reduced Inhibitory Control Mediates the Relationship Between Cortical Thickness in the Right Superior Frontal Gyrus and Body Mass Index.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2016Article
- Impact of plasma transaminase levels on the peripheral blood glutamate levels and memory functions in healthy subjects.BBA clinical · 2016Article
- Recognizing Binge-Eating Disorder in the Clinical Setting: A Review of the Literature.The primary care companion for CNS disorders · 2016Review
- Lisdexamfetamine in the treatment of moderate-to-severe binge eating disorder in adults: systematic review and exploratory meta-analysis of publicly available placebo-controlled, randomized clinical trials.Neuropsychiatric disease and treatment · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Growing evidence suggests that pharmacotherapy may be beneficial for some patients with binge eating disorder (BED), an eating disorder characterized by repetitive episodes of uncontrollable consumption of abnormally large amounts of food without inappropriate weight loss behaviors. In this paper, we provide a brief overview of BED and review the rationales and data supporting the effectiveness of specific medications or medication classes in treating patients with BED. We conclude by summarizing these data, discussing the role of pharmacotherapy in the BED treatment armamentarium, and suggesting future areas for research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.